webinar – ODwire.org

6 Share

Understanding VKC: Not “Just an Allergy”

Vernal keratoconjunctivitis (VKC) is a seasonally recurring, bilateral, and severe form of allergic inflammation affecting the ocular surface. This relatively uncommon type of allergic eye disease can cause severe damage to the ocular surface, leading to corneal scarring and vision loss if not treated properly. The disease happens in children as well as adults with a male preponderance in children.

Join us for a great discussion, with leading experts Dr. Susan Resnick and Dr. Susan J. Gromacki as we dive into a comprehensive overview of VKC, its impact on QoL of patients, management and addressing treatment gaps in Adult VKC.

14 Share

Technology Webinar

OCT Angiography: Age Related Macular Degeneration with Dr. Julie Rodman

In this practice building with OCTA webinar, Dr. Julie Rodman expands on her most recent webinar, “OCT Angiography: How to apply the data clinically for diabetes management,” to discuss Age Related Macular Degeneration (AMD) and the outer retina.

She will present a step-by-step guide to assessing the outer retina with OCTA, applying the data clinically, and incorporating AngioAnalytics to monitor disease progression over time.

Attendees of this course will explore:

• How to assess the outer retina with OCTA
• How to apply OCTA data clinically for AMD
• How to monitor retinal disease over time

This webinar is ideal for clinicians and practice owners looking to learn how to utilize OCTA to assess Age Related Macular Degeneration (AMD) and outer retinal disease.

Discuss Here

8 Share

Technology Webinar

More Efficient Field Testing Using VR with Dr. Paul Karpecki

Like any test that has evolved over time, today’s visual field tests have grown more accurate and reliable, but legacy systems have remained cumbersome for patients and practices alike.

In this ODwire.org webinar, Paul Karpecki, OD, explores how advancements in technology can help your practice overcome the limitations of legacy visual field tests.

He will discuss how the combination of Virtual Reality headsets with advanced, time-tested software, will lead to more efficient and accurate testing with a positive patient experience.

Attendees of this course will learn:

* How new technology can increase comfort and decrease anxiety for the patient, technician and practitioner

* How features like Active Eye Tracking provide reliable visual field results

* Why new testing modalities will improve testing speed and clinic efficiency

About Paul Karpecki, OD:

As a practicing Optometrist and Medical Director of KEPLR Vision, Dr. Karpecki leverages his expansive clinical expertise and business acumen to elevate the role of Optometry.

He is committed to innovation and collaborates to bring new technologies and innovative treatments to the Optometric space. He serves as Director of Cornea Services at Kentucky Eye Institute in Lexington, KY, Gaddie Eye Centers in Louisville, KY and Center for Sight in Carmel, IN.

In addition to completing a full year Retina Fellowship at one of the top 20 US practices, Retina Associates of Kentucky, he is the Associate Professor at the University of Pikeville Kentucky of Optometry.

In addition, Dr. Karpecki serves as Chief Medical Editor for Review of Optometry and has authored 30+ peer reviewed articles, 400+ non-peer reviewed and 7 book chapters.

About the featured technology:

The Smart System | VR Headset by M&S Technologies is a programmable VR Headset with Surface Pro 7 tablet that is powered by time-tested software for fast, accurate and convenient visual field testing.

This portable device includes Active Eye Tracking Functionality, QuickScreen Visual Field testing with full Threshold testing in 3 minutes per eye, and an intuitive interface for ease of use.

DISCUSS HERE

15 Share

Technology Webinar

OCT Angiography: How to Apply the Data Clinically for Diabetes Management with Dr. Julie Rodman

Optical Coherence Tomography Angiography, or OCTA, is new, non-invasive approach to visualizing retinal vasculature that is transforming the way physicians see diabetes.

In this practice building with OCTA series, recognized thought leader Dr. Julie Rodman discusses how to see retinal vasculature without having to refer patients out, visualize signs of disease earlier, make more intelligent referrals, manage more pathology, and elevate the practice with state-of-the-art imaging technology.

Attendees of this course will explore:
• The difference in time domain OCT, spectral domain OCT, and OCTA
• How OCT Angiography works
• How to apply the data clinically for inner retinal disease management

This webinar is ideal for clinicians and practice owners looking to learn more about the clinical impact of OCT Angiography for inner retinal disease, specifically diabetic eye disease.

Discuss this webinar & ask questions in this thread

3 Share

Webinar

Introducing the Wellness Exam Scan with Dr. Julie Rodman

The Wellness Exam is a proprietary scan that provides an invaluable snapshot of a patient’s ocular health prior to the patient examination.

Recognized thought leader and CEwire speaker Dr. Julie Rodman facilitates a practice growth webinar series starting with a comprehensive review of the Optovue Wellness and AngioWellness features and discusses how the data can be used as an assessment tool that uncovers the need for more extensive, problem-specific imaging.

Attendees of this course will explore:

* How to incorporate the Wellness program into their practices to diagnose and manage more diseases
* How to interpret scans including retina, glaucoma, and anterior segment
* How to integrate advanced OCT imaging into their daily workflow

This webinar is ideal for clinicians and practice owners looking to enhance the patient experience, discover disease and grow their business through the implementation of Wellness.

Discuss this webinar & ask questions in this thread

11 Share

Webinar

Using Integrated Telehealth to Expand your Reach

What role does telehealth play in Optometry?
What can a practice owner do to provide on-demand, patient-centric care?

In this ODwire.org Webinar, Rasa Tamulavichus, OD — the founder of Big City Optical with over 16 years of practice experience and 16 locations to date — will present a practice owner’s point of view on new technology investment and how she utilizes the latest innovations to grow and scale her business while enhancing the patient experience.

She will describe how the right technology combination allows her to provide exceptional patient care as the primary care doctor for the eye.

We will explore how today’s most advanced and highly automated technologies will empower owners and eye care professionals to evolve their practice and elevate the complete customer experience.

We’ll also dive into how implementing Visionix® solutions has also allowed her to be an effective educator and patient advocate.

The webinar will explore:

* How Dr. Tamulavichus reimagined patient care during a pandemic
* How to reimagine the role of the Optometrist
* How to reimagine the patient experience

This webinar is ideal for clinicians and practice owners looking to enhance the patient experience and grow their business through the implementation of telehealth.

Discuss this webinar & ask questions in this thread

0 Share

Webinar

Focus on Vernal Keratoconjunctivitis: A Case Based Discussion

In this talk, Drs. Clare Halleran and Susan Resnick for an update on vernal keratoconjunctivitis (VKC), an allergic eye disease that can be debilitating.

They provide a refresher on the clinical presentation of VKC and discuss the burden it has on patients and their caregivers.

Drs. Halleran and Resnick then lead an engaging discussion around:

Diagnosing VKC and differentiating it from atopic keratoconjunctivitis
Non-pharmacologic and pharmacologic options
Approaching and managing this burdensome disease

If you have any questions, feel free to ask them in this thread

6 Share

Webinar

Ptosis or a Different Diagnosis: Identifying and Managing Ptosis

In this ODwire.org Webinar, Dr. Kelly Malloy and Dr. Susan Resnick give us a case-based discussion on acquired blepharoptosis (ptosis). They cover:

• Risk factors for ptosis
• Differential diagnosis
• Patient case studies
• Current treatment options

A Live Q&A follows the cases!

About the Speakers

Kelly A. Malloy, OD, FAAO is the Chief of the Neuro-Ophthalmic Disease Service at the The Eye Institute of the Pennsylvania College of Optometry

Susan A. Resnick, OD, FAAO, FSLS is a principal at Drs. Farkas, Kassalow, Resnick & Associates in New York City.

Hope to see you there!

Discuss this webinar & ask questions in this thread.

0 Share

Webinar

Digital Transformation: How to Future Proof your Practice

As you continue to see patients in the “new normal”, it will be essential to increase the speed of patient throughput to make up for canceled appointments, while balancing making the most of every visit.

If going digital is one of your long-term business objectives, it has become an even more relevant strategy today. Digital refraction offers one way forward to jumpstart your digital transformation while providing an integrated platform for remote-ready eye exams.

Jordan Jones, OD, optometrist and director at Wear Eyewear, explores the value of digital transformation — before, during and beyond the pandemic.

This webinar takes a closer look at the benefits of Visionix® VX65 digital refraction and integrated Visionix® solutions to evolve your practice and help more patients.

Attendees of this course will:

* Explore the clinical application of implementing integrated Visionix® solutions to start digital transformation,
* Understand the benefits of the remote-ready and tablet-driven operation,
* Navigate return on investment (ROI) considerations.

23 Share

Webinar

Managing Ptosis in Your Practice

In this ODwire.org webinar, Melissa Barnett, OD and Susan Resnick, OD help us learn more about ptosis, including causes, diagnosis, treatment landscape, impact on patients, and opportunity for your practice.

Jason Bacharach, MD, introduces the first and only FDA-approved pharmacologic treatment for acquired blepharoptosis, RVL-1201 (oxymetazoline hydrochloride ophthalmic solution), 0.1%, including its mechanism of action and clinical data.

webinar – ODwire.org

Webinars